Literature DB >> 35550436

Advances in antibody phage display technology.

Line Ledsgaard1, Anne Ljungars2, Charlotte Rimbault2, Christoffer V Sørensen2, Tulika Tulika2, Jack Wade2, Yessica Wouters2, John McCafferty3, Andreas H Laustsen4.   

Abstract

Phage display technology can be used for the discovery of antibodies for research, diagnostic, and therapeutic purposes. In this review, we present and discuss key parameters that can be optimized when performing phage display selection campaigns, including the use of different antibody formats and advanced strategies for antigen presentation, such as immobilization, liposomes, nanodiscs, virus-like particles, and whole cells. Furthermore, we provide insights into selection strategies that can be used for the discovery of antibodies with complex binding requirements, such as targeting a specific epitope, cross-reactivity, or pH-dependent binding. Lastly, we provide a description of specialized phage display libraries for the discovery of bispecific antibodies and pH-sensitive antibodies. Together, these methods can be used to improve antibody discovery campaigns against all types of antigens.
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Antibody discovery; Antigen presentation; Library design; Phage display; Selection strategy

Mesh:

Substances:

Year:  2022        PMID: 35550436     DOI: 10.1016/j.drudis.2022.05.002

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   8.369


  1 in total

1.  PDL1Binder: Identifying programmed cell death ligand 1 binding peptides by incorporating next-generation phage display data and different peptide descriptors.

Authors:  Bifang He; Bowen Li; Xue Chen; Qianyue Zhang; Chunying Lu; Shanshan Yang; Jinjin Long; Lin Ning; Heng Chen; Jian Huang
Journal:  Front Microbiol       Date:  2022-07-15       Impact factor: 6.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.